A review of arsenic poisoning and its effects on human health

Critical Reviews in Environmental Science and Technology

Volumn 29, Issue 3, 1999, Pages 281-313

  Saha, J C ^a   Dikshit, A K ^a   Bandyopadhyay, M ^a   Saha, K C ^b,c  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^c Sector 1 ^*  (India)

Author keywords

Acute toxicity; Arsenicosis; Cancer; Chronic toxicity; Ground water; Keratosis; Melanosis; Remedy

Indexed keywords

ARSENIC POISONING; ARSENICOSIS; KERATOSIS; MELANOSIS;

BIOLOGICAL MATERIALS; CONTAMINATION; DIAGNOSIS; GROUNDWATER; HEALTH HAZARDS; MEDICINE; POTABLE WATER; TOXICITY; WATER QUALITY;

ARSENIC;

ARSENIC; DRINKING WATER; GROUND WATER;

ARSENIC; DRINKING WATER; GROUNDWATER POLLUTION; HEALTH IMPACT; IRRIGATION; POISONING;

ACUTE TOXICITY; ARTICLE; CHRONIC TOXICITY; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INGESTION; INHALATION; INTOXICATION; KERATOSIS; MELANOSIS; SKIN ABSORPTION; TISSUE DISTRIBUTION; WATER POLLUTANT; WATER POLLUTION;

EID: 0032805611     PISSN: 10643389     EISSN: None     Source Type: Journal    
DOI: 10.1080/10643389991259227     Document Type: Article

References (144)

1. Abernathy, C. O. and Ohanian, E. V. Health effects of inorganic arsenic in drinking water. Proc. AWWA WQTC, Miami, Fla., Nov. 7-11, 1993.
2. American Conference of Governmental Industrial Hygienists (ACGIH). Documentation of the threshold limit values and Biological Exposure Indics. 5th ed. ACGIH, Cincinnati, OH, 1986.
3. Armstrong, C. W., Stroube, R. B., Rubio, T., and Beckett, W. S. Outbreaks of fatal arsenic poisoning caused by contaminated drinking water. Arch. Environ. Health 39, 274-279, 1984.
4. Axelson, O., Dahlgren, E., Jansson, C. D., and Rehnlund, S. O. Arsenic exposure and mortality. A case reference study from a Swedish copper smelter. Br. J. Ind. Med. 35, 8-15, 1978.
5. Baetjer, A. M., Lilienfeld, A. M., and Levin, M. I. Cancer and occupational exposure to inorganic arsenic. In: Abstracts 18th International Congress on Occupational Health, Brighton, England. 14-19, 1975.
6. Bansal, S. K., Haldar, N., Dhand, U. K. et al. Phrenic neuropathy on arsenic poisoning. Int. J. Dermatol. 30, 304-306, 1991.
7. Barrett, J. C., Lamb, P. W., Wang, T. C., and Lee, T. C. Mechanisms of arsenic induced cell transformation. Biol. Trace Elem. Res. 21, 421-429, 1989.
8. Beckman, G., Beckman, L., and Nordenson, I. Chromosomal aberration in workers exposed to arsenic. Environ. Health Perspect. 19, 145-146, 1977.
9. Belton, J. C., Benson, N. C., Hanna, M. L., and Taylor, R. T. Growth inhibitory and cytotoxic effects of three arsenic compounds on cultured Chinese hamster ovary cells. J. Environ. Sci. Health 20A, 37-72, 1985.
10. Bencko, V., Wagner, V., Wagnerova, M., and Botora, J. Immunological profiles in workers of a power plant burning coal rich in arsenic content J. Hyg. Epidemiol. Microbial. Immunol. 32, 137-147, 1988.
11. Bencko, V. Carcinogenic, teratogenic and mutagenic effects of arsenic. Environ. Health Perspect. 19, 179-182, 1977.
12. Bickley, L. K. and Papa, C. M. Chronic arsenicism with vitiligo, hyperthyroidism, and cancer. N. J. Med. 86, 377-380, 1989.
13. Borgono, T. M. and Greiber, R. Epidemiological study of arsenicism in the city of Antofagasta. Trace Subst. Environ. Health 5, 13-24, 1972.
14. Brown, J. P. et al. Pharmacokinetic modelling of inorganic arsenic in rodents and humans: short-term exposure. Society of environmental geochemistry and health workshop on arsenic. Epidemiology and PBPK Modelling, Annapolis, MD, June 27-28, 1994.
15. Buchanan, W. D. Toxicity of Arsenic Compounds. Elsevier, New York, 1962, 15-66.
16. Buchet, J. P., Lauwerys, R., and Roels, H. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethyl arsonate or dimethyl arsenite in man. Int. Arch. Occup. Environ. Health 48, 71-79, 1981a.
17. Byron, W. R., Bierbower, G. W., Brouwer, J. B., and Hanse, W. H. Pathological changes in rates and dogs from two year feeding of sodium arsenite or sodium arsenate. Toxicol. Appl. Pharmacol. 10, 132-147, 1967.
18. Calabrese, E. J., Kostecki, P. T., and Gilbert, C. E. How much soil do children eat? An emerging consideration for environmental health risk assessment. Comments Toxicol. 1, 229-241, 1987.
19. Campbell, J. P. and Alvares, J. A. Acute arsenic intoxication. Am. Fam. Physician. 40, 93-97, 1989.
20. Caroli, F., La Torre, Petrucci, F., and Violante, N. Element speciation in bioinorganic chemistry, Caroli, S., Ed., Chemical Analysis Series, 135, 445-463, 1996.
21. Cebrian, M. E., Albores, A., Anguilar, M., and Blakely, E. Chronic arsenic poisoning in the north of Mexico. Hum. Toxicol. 2, 121-133, 1983.
22. Chakraborty, A. K. and Saha, K. C. Arsenical dermatosis from tube-well water in West Bengal. Indian J. Med. Res. 85, pp 326-334, 1987.
23. Chisholm, J. J., Jr. Arsenic poisoning from rodenticides. Pediatric Clinic North Am. 17, 591, 1970.
24. Clarkson, T. W. Inorganic and organometal pesticides. In: Handbook of Pesticide Toxicology. Hayes, W. J., Jr. and Laws, E. R., Jr., Eds., Academic Press, San Diego, 1991, 545-552.
25. Dannan, M., Dally, S., and Conso, F. Arsenic induced encephalopathy (letter). Neurology 34, 1529, 1984.
26. Datta D. V. Arsenic and non-cirrhotic portal hypertension. Lancet, 1, 433, 1976.
27. Dekundt, G. L., Leonard, A., Arany, J., DuBuisson, G. J., and Delavignetta, E. In vivo studies in male mice on the mutagenesis effects of inorganic arsenic. Mutagenesis. 1, 33-34, 1986.
28. Ding, G. et al. Epidemiologic research of cancer in exposed cadmium, lead and arsenic workers. J. China Med. Univ. 16, 368-371, 1987.
29. Donofrio, P. D. and Wilbourn, A. J. Subacute arsenic toxicity presenting on clinical and electromyographic examination as Guillain-Barre syndrome. Ann Neurol. 18, 156-157, 1985.
30. Douen, A. G. and Jones, M. N. Phenylarsine oxide and the mechanism of insulin-stimulated sugar transport. Biofactors 2, 153-161, 1990.
31. Environmental Protection Agency (EPA). Life systems Inc. Draft drinking water criteria document on arsenic. USEPA Human Risk Assessment Branch. Washington, D.C., 1993.
32. Environmental Protection Agency (EPA). Risk assessment Forum. Special Report on Ingested Inorganic Arsenic: Skin cancer, Nutritional Essentiality, Draft Report, EPA/625/3-87/ 013. USEPA, Washington, D.C., 1988.
33. Environmental Protection Agency (EPA). Health Assessment Document for inorganic arsenic. Final report, EPA, 600/8-83-021F. USEPA. Environmental criteria and assessment office. Research Triangle Park, N.C, 1984.
34. Feinsilber, D. G. M., Cha, D. M., Lemos, A., Pacheco, E., and Kogan, N. Chronic iatrogenic arsenic poisoning. Rev. Argent Dermatol. 71, 178-184, 1990.
35. Feldman, R. G., Niles, C. A., Kelly-Hayes, M., and Wilson, G. Peripheral neuropathy in arsenic smelter workers. Neurology 29, 939-944, 1979.
36. Fennel, J. S. and Stacy, W. K. Electrocardiographic changes in acute arsenic poisoning. Ir. J. Med. Sci. 150, 338-339, 1981.
37. Fernandez-Sola, J., Nogue, S., Grau, J. M., Casademont, J., and Munnu, P. J. Toxicol. Clin. Toxicol. 29, 131-136, 1991.
38. Fierz, U. Catamnestic research into the side effects of inorganic arsenotherapy in skin diseases. Dermatologica 131, 41-58, 1965.
39. Fishbein, L. Perspectives of carcinogenic and mutagenic metals in biological samples. Int. J. Environ. Annl. Chem. 28, 21-69, 1987.
40. Food and Agriculture Organization (FAO) and World Health Organization (WHO). WHO Food Addit, Ser. 18. 1983.
41. Food and Agriculture Organization (FAO) and World Health Organization (WHO). Toxicological evaluation of certain additives contaminants. 33rd Meet, Jt, FAO/WHO expert Comm. Food Addit., Geneva, 1989.
42. Fowler, B. A. and Weissburg, J. B. Arsine poisoning. N. Engl. J. Med. 291, 1171-1174, 1974.
43. Franzblau, A. and Lilis, R. Acute arsenic intoxication from environmental arsenic exposure. Arch. Environ. Health, 44, 385-390, 1989.
44. Franklin, M., Bean, W., and Harden, R. C. Fowler's solution as an ecological agent in cirrhosis. Am. J. Med. Sci. 219, 589-596, 1950.
45. Frost, F., Milham, H. L., Royce, R., Smith, A. H., Hartley, J., and Enterline, P. Lung cancer among women residing close to an arsenic emitting copper smelter. Arch Environ. Health 42, 148-152, 1987.
46. Frost, S. C. and Schwalbe, M. S. Uptake and binding of radio-labelled phenylarsine oxide in 3T-L1 adipocytes. Biochem. J. 269, 589-595, 1990.
47. Fuortes, L. Arsenic poisoning. Postgrad. Med. 83(1), 233-244, 1988.
48. Gerhardsson, L., Dahlgren, E., Eriksson, A., Lagerkvist, B. E. A., Lundstrom, J., and Nordberg, G. P. Fatal arsenic poisoning-a case report. Scand. J. Work Environ. Health 14, 130-133, 1988.
49. Giberson, A., Vaziri, N. D., Mirahamadi, K., and Rosen, S. Hemodialysis of acute arsenic intoxication with transient renal failure. Arch. Intern. Med. 136, 1303-1304, 1976.
50. Glazener, F. S., Ellis, J. G., and Johnson, P. K. Electrocardiographic findings with arsenic poisoning. Calif. Med. 109, 158-162, 1968.
51. Godman, A. L. Lung cancer in Bowen's disease. Am. Rev. Resp. Dis. 188, 1205-1207, 1973.
52. Goebel, H. H., Schmidt, P. E., Bohl, J., Tettenborn, B. Kramer, G., and Guttman, L. Polyneuropathy due to arsenic intoxication: Biopsy studies. J. Neuropathol. Exp. Neurol. 49, 137-149, 1990.
53. Goldsmith, S. and From, A. H. Arsenic-induced atypical ventricular tachycardia. N. Engl. Med. 303, 1096-1097, 1986.
54. Goodman, L. and Gilman, A. The Pharmacology Basis of Therapeutics. Macmillian, New York, 1942.
55. Gordon, J. J. and Quastel, G. H. Effect of organic arsenicals on enzyme system. Biochem. J. 42, 337-350, 1948.
56. Goyer, R. A. Toxic effect of metals. In: Toxicology, Amdur, M. O., Doull, J., and Klaassen, C. D., Eds., Pergamon Press, New York, 1991, 629-633.
57. Graziano, J. H. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med. Toxicol. 1, 155-162, 1986.
58. Henriksen, E. J. and Holloszy, J. O. Effect of phenylarsine oxide on stimulation of glucose transport in rat skeletal muscle. Am. J. Physiol. 258, C648-C653, 1990.
59. Hindmarsh, J. T. and McCurdy, R. F. Clinical and environmental aspects of arsenic toxicity. Crit. Rev. Clin. Lab. Sci. 23, 315-317, 1986.
60. Hoffman, G. R. Genetic toxicology. In: Toxicology, Amdur, M. O., Doull, J., and Klaassen, C. D., Eds., Pergamon Press, New York, 1991, 201-225.
61. Huang, Y. Z., Quan, X. C., and Wang, G. Q. Endemic chronic arsenism in Xinjiang. Chin. Med. J. (Peking. Engl. Eds.) 98, 219-222, 1985.
62. Hughes, J. P., Polissar, L., Van Belle, G. Evaluation and synthesis of health effects studies of communities surrounding arsenic producing industries. Int. J. Epidemiol. 17, 407-413, 1988.
63. Hunter, F. T., Kip, A. F., and Irvine, W. Radioactive tracer studies on arsenic injected as potassium arsenite. J. Pharmacol. Exp. Ther. 76, 207, 1942.
64. IARC. Monograph arsenic and its compounds. Lyons International Agency for Research on Cancer. 23, 39-41, 1980.
65. Ide, C. W. and Bullough, G. R. Arsenic and old glass. J. Soc. Occup. Med. 38, 85-88, 1988.
66. International Agency for Research on Cancer (IARC). Monograph on the evaluation of the carcinogenic risk of chemicals to humans. 23, IARC, Lyon, France, 1990.
67. Kyle, R. A. and Pearse, G. L. Haematological aspects of arsenic intoxication. N. Engl. J. Med. 273, 18-23, 1965.
68. La Dou, J. Potential occupational health hazards in the micro-electronics industry. Scand. J. Environ. Health 9, 42-46, 1983.
69. Lee, A. M. and Fraumeni, J. F., Jr. Arsenic and respiratory cancer in man. An occupational study. J. Natl. Cancer Inst. 42, 1045-1052, 1969.
70. Lee-Feldstein, A. Arsenic and respiratory cancer in man: follow-up of an occupational study. In: Arsenic: Industrial, Biomedical and Environmental Perspectives. Lederer, W. and Festerheim, R., Eds., Van Nostrand-Reinhold, New York, 1983, 245-265.
71. Leonard. A. and Lauwerys, R. R. Carcinogenicity, teratogenicity, and mutagenicity of arsenic. Mutat. Res. 75, 49-62, 1980.
72. Lerman, B. B., Ali, N., and Green, D. Megaloblastic dyserythropoietic anaemia following arsenic ingestion. Ann. Clin, Lab. Sci. 10, 515-517, 1980.
73. Leslie, A. C. D. and Smith, H. Self-poisoning by the abuse of arsenic containing tonics. Med. Sic. Law. 18, 159-162, 1978.
74. Li, J. H. and Rossman, T. G. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol. 2, 1-9, 1989.
75. Livadttov, A., Alexion, G., Floros, D., Filippidis, T., Do Ios, T., and Bays, D. Epitheloid angiosarcoma of the adrenal gland associated with chronic arsenical intoxication pathol. Res. Pract. 187, 284-289, 1991.
76. Maegraith, B. In: Tropical Eosinophilia. Price's Textbook of Medicine. Oxford University Press, Bombay, 1966.
77. Mathieu, D., Mathieu-Nolt, M., Germain-Alonso, M., Nevere, R., Furon, D., and Wattel, F. Massive arsenic poisoning-effect of hemodialysis and dimercaprol on arsenic kinetics. Intensive Care Med. 18, 47-50, 1992.
78. Mazumdar, D. N. G., Chakraborty, A. K., Ghosh, A., Gupta, J. D., Chakraborty, D. P., Day, S. B., and Chatoopadya, S. Chronic arsenic toxicity from drinking tubewell water in rural West Bengal. Bull. W. H. O. 66, 499-506, 1988.
79. McDonnell, J. M., Mayr, A. J., and Martin, W. J. DNA of human papilloma virus type 16 in dysplastic and malignant lesions of the conjunctive and cornea. N. Engl. J. Med. 320, 1442-1446, 1989.
80. McKinney, J. D. Metabolism and disposition of inorganic arsenic in laboratory animals and humans. Environ. Geochem. Health 14, 43, 1992.
81. Mizuta, N., Mizula, M., and Ita, F. An outbreak of acute arsenic poisoning caused by arsenic contaminated soysouce (Shoyu): a clinical report of 220 cases. Bull. Yamaguchi Med. Sch. 4, 131-150, 1956.
82. Moore, J. E. In Modern Treatment of Syphilis. Charles C Thomas, Springfield, III, 1933.
83. Morton, W. E. and Caron, G. A. Encephalopathy: an uncommon manifestation of workplace arsenic poisoning. Am. J. Ind. Med. 15, 1-5, 1989.
84. Most, H. Drug therapy - Treatment of common parasitic infection of man encountered in the United States. N. Engl. J. Med. 287, 698, 1972.
85. Nagymajtenyi, L., Selypes, A., and Berencsi, G. Chromosomal abberations and fetotoxic effects of atmospheric arsenic exposure in mice. J. Appl. Toxicol. 5, 61-63, 1985.
86. Nakamuro, K. and Sayato, T. Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mutat. Res. 88, 73-80, 1981.
87. Naqvi, S. M., Vaishnavi, C., and Singh, H. Toxicity and metabolism of arsenic in vertebrates. In: Arsenic in the Environment. II. Human Health and Ecosystem Effects, Nriagu, J. O., Ed., 1994, 55-91.
88. Nash, T. A. Review of the African trypanosomiasis problem. Trop. Dis. Bull. 57, 973-1013, 1960.
89. National Institute of Occupational Safety and Health (NIOSH). Arsine (Arsenic Hydroxide) poisoning in the workplace. Current Intelligence Bulletin 32, NIOSH, Cincinnati, OH, 1979.
90. NAS. Medical and biological effects of environmental pollutants: Arsenic. National Academic of Science, Washington, D.C., 1977.
91. National Academy of Sciences (NAS). Drinking water and Health. NAS. Washington, D.C. 1977b, 316-344, 428-430.
92. Neubauner, O. Arsenical cancer: a review. Br. J. Cancer. 1, 192-251, 1947.
93. Nordenson, I., Sweins, A., and Beckman, L. Chromosome abberations in cultured human lymphocytes exposed to trivalent and pentavalent arsenic. Scand. J. Work. Environ. Health 7, 277-281, 1981.
94. Nordenson, I. and Beckman, L. Is the genotonic effect of arsenic mediated by oxygen-free radicals ? Hum. Hered. 41, 71-73, 1991.
95. Nordenson, I., Salmonsson, S., Brun, E., and Bechman, G. Occupational and environmental risks in and around a smelter in northern Sweden. II. Chromosomal aberrations in workers exposed to arsenic. Hereditas 88, 47-50, 1978.
96. Norstrom, S., Beckman, L., and Nordenson, I. Occupational and environmental risks in and around a smelter in northern Sweden. V. Spontaneous abortion among female employees and decreased birth weight in their offspring. Hereditas 90, 291-296, 1979a.
97. Norstrom, S., Beckman, L., and Nordenson, I. Occupational and environmental risks in and around a smelter in northern Sweden. I. Variations in birthweight, Hereditas 88, 43-46, 1978a.
98. Norstrom, S., Beckman, L., and Nordenson, I. Occupational and environmental risks in and around a smelter in northern Sweden. VI. Congenital malformations. Hereditas 90, 297-302, 1979b.
99. Nriagu, J. O. and Azcue, J. M. Food contamination with arsenic in the environment. Adv. Environ. Sci. Technol. 23, 121-143, 1990.
100. Okui, T. and Fujiwara, Y, Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutat. Res. 172, 69-76, 1986.
101. Penrose, C. R. Crit. Rev. Environ. Control 4, 465, 1974.
102. Pershagen, G., Elinder, C. G., and Bolander, A. M. Mortality in a region surrounding an arsenic emitting plant. Environ. Heath Perspect. 19, 133-137, 1977.
103. Pershagen, G., Braman, R. S., and Vahter, M. In: Environmental Health Criteria 18: Arsenic, World Health Organ. Geneva, 1981, 76-146.
104. Pershagen, G. The carcinogenicity of arsenic. Environ. Health Perspect. 40, 93-100, 1981.
105. Peterson, R. G. and Rumack, B. H. D-Penicillamine therapy of acute arsenic poisoning. J. Pediatr. 91, 661-666, 1977.
106. Pinto, S. S. and McGill, C. M. Arsenic trioxide exposure in industry. Ind. Med. Sura. 22, 281-287, 1953.
107. Piontek, M., Hengels, K. J., and Borchard, F. Noncirrhotic liver fibrosis after chronic arsenic poisoning. Dtsch. Med. Wochenschr. 114, 1653-1657, 1989.
108. Reynold, E. S. In account of epidemic outbreak of arsenical poisons occurring in Beer drinkers in north of England and the Midland Countries in 1900. Lanccl. 1, 166-170, 1901.
109. Rosenberg, H. G. Systematic arterial disease and chronic arsenism in infants. Arch Pathol. 97, 360-365, 1974.
110. Rossman, T. G., Meyn, M. S., and Troll, W. Effects of arsenic on DNA repair in Escherichia coli. Environ. Health Prespect. 19, 229-233, 1977.
111. Roth, F. The sequelae of chronic arsenic poisoning in Moselle vintners. Ger. Med. Mon. 2, 172-175, 1957.
112. Saha, K. C. Melanokeratosis from arsenic-contaminated tubewell water. Ind. J. Dermatol. 29(4), 37-46, 1984.
113. Saha, K. C. Chronic arsenical dermatoses from tube-well water in West Bengal during 1983 to 1987. Indian J. Dermatol. 40(1), 1-12, 1995.
114. Saha, K. C. Arsenic poisoning from groundwater in West Bengal. Breakthough 7(4), 5-14, 1998.
115. Schoolmeester, W. L. and White, D. R. Arsenic poisoning. South Med. J. 73, 198-208, 1980.
116. Silver, A. S. and Weinman, P. L., Chronic arsenic poisoning following use of an asthma remedy. JAMA 250, 584-585, 1952.
117. Sittig, M. Handbook of Toxic and Hazardous Chemicals and Carcinogens, 2nd ed. Noyes Publications, ParkRidge, NJ, 1985.
118. Southwick, J. W., Western, A. E., and Beck, M. M. Community Health Associated with arsenic in drinking water in Millard Country. Utah. EPA-600/1-81-064, NTIS No. PB82-108374, USEPA, Health Effects Laboratory, Cincinnati, OH, 1981.
119. Squibb, K. S. and Fowler, B. A. The toxicity of arsenic and its compounds. In: Biological and Environmental Effects of Arsenic. Fowler, B. A., Ed., Elsevier, New York, 1983, 233-269.
120. Stohrer, G. Arsenic: opportunity for risk assessment. Arch. Toxicol. 65, 525-531, 1991.
121. Sunderman, F. W., Jr. Carcinogenicity and mutagenicity of some metals and their compounds. In: Environmental Carcinogens - Selected Methods in Analysis. O'Neill, I. K., Schuller, P., and Fishbein, L., Eds., 8, 17-43, 1986.
122. Tay, C. H. and Seah, C. S. Arsenic poisoning from anti-asthmatic herbal preparations. Med. J. Aust. 2, 424-428, 1975.
123. Thompson, D. J. Achemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact. 88, 89, 1993.
124. Tseng, W. P., Chu, H. M., How, S. W., Fong, J. M., Lin, C. S., and Yeh, S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40, 453-463, 1968.
125. Tseng, W., Chen, V. et al. A clinical study of black foot disease. Memories College Med. 7, 1-18, 1961.
126. Tseng, W. P. Effect of dose-response relationships of skin cancer and Blackfoot disease with arsenic. Environ. Health Perspect. 19, 109-119, 1977.
127. Tsuda, T., Babazono, A., Ogawa, T., Hamada, H., Aoyama, H., Kurumatano, N., Nagira, T., Hotta, N., Harada, M., and Inomata, S. Inorganic arsenic: a dangerous enigma for mankind. Appl. Organomat. Chem. 6 (in press), 1992.
128. USEPA. Science advisory board. Science advisory board's review of the arsenic issue relating to phase II. Proposed regulations from the office of drinking water. EPA-SAB-EHC-89-038. Memorandum to William K. Reilly, 1989.
129. U.S. Public Health Service. Toxicological profile for arsenic. USEPA, Washington, D.C., 1989.
130. Valee, B. L. Ulmer, D. D., and Wacker, W. E. C. Arsenic toxicity and biochemistry. Arch. Ind. Heath, 21, 132-151, 1960.
131. Valentine, J. L., Reisbord, L. S., Kang, H. K., and Schluchter, M. D. Arsenic effects of population health histories, In: Trace Elements in Man and Animals. Mills, C. F. and Bremner Im chesters, K. J., Eds., Commonwealth Agricultural Bureau, Slough, U.K. 1985, 289-294.
132. Vater, M. Methylation of arsenic. In: Biological and Environmental Effects of Arsenic. Fowler, B. A., Ed., Elsevier, New York, 1988, 171-198.
133. Wall, S. Survival and mortality pattern among Swedish smelter workers. Int. J. Epidemiol. 9, 73-87, 1980.
134. Wang, L. and Huang, J. Chronic arsenism from drinking water in some areas of Xinjiang, China. Arsenic in the Environment, Part II, Human Health and Ecosystem Effect. 1994.
135. Westhoff, D. D., Samaha, R. J., and Barnes, A. Arsenic intoxication as a cause of megaloblastic anemia, Blood. 45, 241-246, 1975.
136. Windhorst, D. B., Albert, R. E., and Boutwell, R. K., Biologic effects of arsenic on man. In: NRC Committee on Medical and Biological Effects of Environmental Pollutants. Arsenic, National Academy of Science, Washington, D.C., 1977, 173-215.
137. Winship, K. A. Toxicity of inorganic arsenic salts. Adv. Drug. React. Acute Poisoning Rev. 3, 129-160, 1984.
138. Wolf, R. On the question of occupational arsenic poisoning in nineyard workers. Berufsdermatosen 22 (1), 34-37, 1974.
139. World Health Organization (WHO). Environmental Health Criteria 18: Arsenic. WHO, Geneva, 1981.
140. Yeh, P. Y., Chang, L. M., and Yeh, F. H. Sodium arsenite induces DNA strand breaks and SI nuclease-sensitive regions. J. Chim. Biochem. Soc. 15, 17-23, 1986.
141. Zachariac, H., Sogard, H., and Nyfors, A. Liver biopsy in psoriatics previously treated with potassium arsenate. Acto Derm Venereol (Stock). 54, 235-236, 1974.
142. Zaldivar, R. Ecological investigations on arsenic dietary intake and endemic chronic poisoning in man; Dose-dependent curve. Zentralbl Bakteriol., Parasitenkd. Infektionskr. Hyg., Abts. I. Orig., Reihe B 164, 481-484, 1977.
143. Zaldivar, R. Arsenic contamination of drinking water and foodstuffs causing endemic chronic arsenic poisoning. Beitr. Pathol. 151, 384-400, 1974.
144. Zierler, S., Theodore, M., and Cohen, A. Chemical quality maternal drinking water and congenital heart disease. Int. J. Epidemiol. 17, 589-594, 1988.